Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease

Stopped early · Phase 3

Conditions studied: Renal Artery Obstruction

In brief

The purpose of this study is to evaluate the safety and effectiveness of the RX HERCULINK 14 Peripheral Stent System in treating atherosclerotic renal artery stenosis.

Key facts

Study ID

NCT00180544

Run by

Abbott Medical Devices

People needed

167

Starts

2000-07-01

Expected to finish

2004-08-01

Last updated by the study team

2008-07-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of renal artery atherosclerosis; candidate for renal artery angioplasty and stenting; blood pressure >160/90

You may not qualify if…

• Totally occluded renal artery on the opposite side; only one functioning kidney; target lesion is in a transplanted kidney; renal insufficiency

Where it is running

• Alton Ochsner Medical Foundation — New Orleans, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.